Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by BEIER DAVID W, Director. Officer active across 1 company, notably Infinity Pharmaceuticals, INC.. In total, 2 reports have been recorded. Activity tracked since 10 June 2021. The latest transaction was filed on 10 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
David W. Beier is a Director at Infinity Pharmaceuticals, Inc., a biopharmaceutical company focused on developing cancer treatments. As a board member, he plays a key role in the governance of the company, bringing his expertise in the biopharmaceutical field to help guide strategic decisions.